India.com News Desk | Sep 21, 2022, 4:04 PM IST
Aviation Regulator Directorate General of Civil Aviation (DGCA) extends restrictions on SpiceJet to operate only 50 per cent of departures till October 29, 2022.
Victor Dasgupta | Jul 20, 2022, 6:02 PM IST
The Minister informed that the number of senior citizen passengers travelled in reserved classes during 2019-20, 2020-21 and 2021-22 are 6.18 crore, 1.90 crore and 5.55 crore,
India.com News Desk | Jul 20, 2022, 4:01 PM IST
Delhi-Guwahati Go First flight diverted to Jaipur after windshield cracks mid-air
India.com News Desk | May 23, 2022, 5:59 PM IST
Akasa Air received the NOC from the Ministry of Civil Aviation in August 2021 to launch commercial flight operations.
India.com News Desk | Feb 21, 2022, 6:24 PM IST
With this, Corbevax became India's third homegrown vaccine, to receive an emergency use approval in India for use in adolescents.
India.com News Desk | Jan 13, 2022, 10:12 PM IST
Issuing a statement, Bharat Biotech said the goals of developing a global vaccine against COVID-19 have been achieved.
India.com News Desk | Dec 30, 2021, 9:14 AM IST
The Ahmedabad unit of Directorate General of GST Intelligence (DGGI) booked Jain under Section 69 of the Central Goods and Services Tax (CGST) Act after recovering unaccounted of over Rs 194.45 crores of cash, 23 kilogram (kg) gold, 600 kg sandalwood during multiple raids.
India.com News Desk | Dec 20, 2021, 5:51 PM IST
The development comes as India has detected over 160 new cases of the emergent Omicron variant of the coronavirus.
India.com News Desk | May 18, 2021, 5:39 PM IST
COVAXIN has been approved by the Drugs Controller General of India (DCGI), for Phase II/III clinical trials in the age group of 2 to 18 years.
India.com News Desk | Apr 23, 2021, 3:39 PM IST
Drugs Controller General of India (DGCI) on Friday approved the emergency use for Zydus Cadila's Pegylated Interferon alpha-2b, 'Virafin' for treating moderate COVID-19 infection in adults.
India.com News Desk | Jan 3, 2021, 6:59 PM IST
Some Congress leaders, including Anand Sharma, Shashi Tharoor and Jairam Ramesh, on Sunday raised serious concerns over the grant of approval to Bharat Biotech's COVID-19 vaccine for restricted use, saying it is "premature" and can prove dangerous.
